CRISPR Trial Provides Hope for Inherited Blindness

Source: Google News - HealthA groundbreaking clinical trial demonstrated the safety and efficacy of CRISPR gene editing in treating inherited blindness. The study, published May 6 in The New England Journal of Medicine, marks the first instance of CRISPR being administered directly inside the body. In the research, 14 participants received a single injection of the CRISPR/Cas9-based medicine, EDIT-101, which showed measurable improvements in 11 participants' vision.